June 21, 2024 07:00 AM EDT
Peer Review

Mon­cef Slaoui joins board at mR­NA biotech; Gami­da Cell re­tools with ex-Am­ryt CEO at the helm

Alex Hoffman

Assistant Editor

Kathy Wong

Editor

→ Mon­cef Slaoui has reemerged this week with an­oth­er board ap­point­ment, mak­ing his way to mR­NA drug de­vel­op­er Arc­turus Ther­a­peu­tics. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA re­jects Dai­ichi Sanky­o's HER3 ADC, a blow to quick ap­proval plans for Mer­ck part­ner­ship

Bio­gen is pur­su­ing more deal­mak­ing this year, with plans to spend up to $8B

Maze spins its ALS an­ti­sense pro­gram in­to a se­cre­tive new com­pa­ny

Ab­b­Vie buys Third Rock­'s Cel­sius for $250M to ex­pand IBD pipeline

Ex­clu­sive: To de­vel­op bet­ter cell ther­a­pies for sol­id tu­mors, a new start­up plans to test hun­dreds of them at once

Sci­en­tists un­veil new way to make large changes to genes, and no CRISPR is re­quired

A service from the Financial Times